Asia Pacific Latent TB Detection Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Latent TB Detection Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Latent TB Detection Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Latent TB Detection Market Regional Analysis

6.2 Asia Pacific Latent TB Detection Market Revenue 2018-2027 (US$ Million)

6.3 Asia Pacific Latent TB Detection Market Forecast Analysis

7. Asia Pacific Latent TB Detection Market Analysis – by Test

7.1 Tuberculin Skin Test

7.1.1 Overview
7.1.2 Tuberculin Skin Test: Asia Pacific Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

7.2 Interferon Gamma Released Assay

7.2.1 Overview
7.2.2 Interferon Gamma Released Assay: Asia Pacific Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

8. Asia Pacific Latent TB Detection Market Analysis – by End User

8.1 Hospitals

8.1.1 Overview
8.1.2 Hospitals: Asia Pacific Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

8.2 Diagnostic Centers

8.2.1 Overview
8.2.2 Diagnostic Centers: Asia Pacific Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

8.3 Laboratories

8.3.1 Overview
8.3.2 Laboratories: Asia Pacific Latent TB Detection Market – Revenue and Forecast, 2018-2027 (US$ Million)

9. Asia Pacific Latent TB Detection Market – Asia-Pacific Analysis

9.1 Overview

9.2 Asia-Pacific

9.2.1 Asia Pacific Latent TB Detection Market Breakdown, by Key Country, 2021 and 2027 (%)
9.2.1.1 Asia Pacific Latent TB Detection Market – Revenue and Forecast Analysis – by Country
9.2.1.1 China: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.1.1 China: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.2.1.1.2 China: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.2.1.2 India: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.2.1 India: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.2.1.2.2 India: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.2.1.3 Japan: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.3.1 Japan: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.2.1.3.2 Japan: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.2.1.4 Australia: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.4.1 Australia: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.2.1.4.2 Australia: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.2.1.5 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market Breakdown, by Test
9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 ARKRAY, Inc.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 BD

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 bioMerieux SA

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 F. HOFFMANN-LA ROCHE LTD.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Lionex GmbH

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Oxford Immunotec Ltd

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 QIAGEN

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Serum Institute of India Pvt. Ltd.

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Asia Pacific Latent TB Detection Market

Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)